2019 Chagas Disease (American Trypanosomiasis) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 67 pages | ID: 28A65E86E38EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Chagas Disease (American Trypanosomiasis) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Chagas Disease (American Trypanosomiasis). It presents in-depth analysis of Chagas Disease (American Trypanosomiasis) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Chagas Disease (American Trypanosomiasis).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Chagas Disease (American Trypanosomiasis) clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Chagas Disease (American Trypanosomiasis)

The research work is prepared through extensive and continuous research on Chagas Disease (American Trypanosomiasis) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Chagas Disease (American Trypanosomiasis) patients are identified
• The report includes panorama of Chagas Disease (American Trypanosomiasis) clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Chagas Disease (American Trypanosomiasis) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Chagas Disease (American Trypanosomiasis) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Chagas Disease (American Trypanosomiasis) Clinical Trials by Region
  2.2.2 Average Enrollment of Chagas Disease (American Trypanosomiasis) Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Chagas Disease (American Trypanosomiasis) Treatment, 2019

3. REGION WISE CHAGAS DISEASE (AMERICAN TRYPANOSOMIASIS) CLINICAL TRIALS

3.1 Asia Pacific Chagas Disease (American Trypanosomiasis) Clinical Trials by Country
3.2 Europe Chagas Disease (American Trypanosomiasis) Clinical Trials by Country
3.3 North America Chagas Disease (American Trypanosomiasis) Clinical Trials by Country
3.4 Middle East and Africa Chagas Disease (American Trypanosomiasis) Clinical Trials by Country
3.5 South and Central America Chagas Disease (American Trypanosomiasis) Clinical Trials by Country

4. CHAGAS DISEASE (AMERICAN TRYPANOSOMIASIS) CLINICAL TRIAL TRENDS

4.1 Start Year wise Chagas Disease (American Trypanosomiasis) Clinical Trials
4.2 Phase wise Chagas Disease (American Trypanosomiasis) Clinical Trials
4.3 Trial Status wise Chagas Disease (American Trypanosomiasis) Clinical Trials
4.4 Trial Type wise Chagas Disease (American Trypanosomiasis) Clinical Trials

5. CHAGAS DISEASE (AMERICAN TRYPANOSOMIASIS) AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Chagas Disease (American Trypanosomiasis) Trials by Year
5.2 Average Enrollment in Chagas Disease (American Trypanosomiasis) Trials by Phase
5.3 Average Enrollment in Chagas Disease (American Trypanosomiasis) Trials by Status
5.4 Average Enrollment in Chagas Disease (American Trypanosomiasis) Trials by Type of Trial

6. COMPANIES PARTICIPATING IN CHAGAS DISEASE (AMERICAN TRYPANOSOMIASIS) CLINICAL TRIALS

6.1 Chagas Disease (American Trypanosomiasis) Trials by Sponsor Type
6.2 Chagas Disease (American Trypanosomiasis) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Chagas Disease (American Trypanosomiasis) Trials- Phase
7.2 Chagas Disease (American Trypanosomiasis) Trials- Phase
7.3 Chagas Disease (American Trypanosomiasis) Trials- Phase
7.4 Chagas Disease (American Trypanosomiasis) Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Chagas Disease (American Trypanosomiasis) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Chagas Disease (American Trypanosomiasis) Clinical Trials and Enrolment
Figure 5: Europe – Country wise Chagas Disease (American Trypanosomiasis) Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Chagas Disease (American Trypanosomiasis) Clinical Trials and Enrolment
Figure 7: North America – Country wise Chagas Disease (American Trypanosomiasis) Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Chagas Disease (American Trypanosomiasis) Clinical Trials and Enrolment
Figure 9: Chagas Disease (American Trypanosomiasis) Clinical Trials by Phase
Figure 10: Chagas Disease (American Trypanosomiasis) Clinical Trials by Trial Status
Figure 11: Chagas Disease (American Trypanosomiasis) Clinical Trials by Type
Figure 12: Chagas Disease (American Trypanosomiasis) Clinical Trials by Sponsor Type
Figure 13: Chagas Disease (American Trypanosomiasis) Clinical Trials by Leading Sponsors
Figure 14: Chagas Disease (American Trypanosomiasis) Average Enrollment by Phase
Figure 15: Chagas Disease (American Trypanosomiasis) Average Enrollment by Trial Status
Figure 16: Chagas Disease (American Trypanosomiasis) Average Enrollment by Type
Figure 17: Chagas Disease (American Trypanosomiasis)- Average Enrolment by Type of Sponsors
Figure 18: Chagas Disease (American Trypanosomiasis)- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Chagas Disease (American Trypanosomiasis) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Chagas Disease (American Trypanosomiasis) Clinical Trials and Enrolment
Table 5: Europe – Country wise Chagas Disease (American Trypanosomiasis) Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Chagas Disease (American Trypanosomiasis) Clinical Trials and Enrolment
Table 7: North America – Country wise Chagas Disease (American Trypanosomiasis) Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Chagas Disease (American Trypanosomiasis) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Chagas Disease (American Trypanosomiasis) Average Enrollment by Phase
Table 15: Chagas Disease (American Trypanosomiasis) Average Enrollment by Trial Status
Table 16: Chagas Disease (American Trypanosomiasis) Average Enrollment by Type
Table 17: Chagas Disease (American Trypanosomiasis)- Average Enrolment by Type of Sponsors
Table 18: Chagas Disease (American Trypanosomiasis)- Enrolment by Leading Sponsors